| 6.07 0.3 (5.2%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.01 | 1-year : | 10.71 |
| Resists | First : | 7.71 | Second : | 9.17 |
| Pivot price | 6.11  |
|||
| Supports | First : | 5.36 | Second : | 4.45 |
| MAs | MA(5) : | 5.95 |
MA(20) : | 6.39 |
| MA(100) : | 7 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 27.1 |
D(3) : | 26.8 |
| RSI | RSI(14): 48.2 |
|||
| 52-week | High : | 15.36 | Low : | 3.43 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CV ] has closed above bottom band by 46.1%. Bollinger Bands are 71.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.12 - 6.16 | 6.16 - 6.2 |
| Low: | 5.72 - 5.77 | 5.77 - 5.8 |
| Close: | 6.01 - 6.08 | 6.08 - 6.14 |
M
Thu, 23 Apr 2026
[EFFECT] CapsoVision, Inc SEC Filing - Stock Titan
Wed, 22 Apr 2026
CapsoVision (NASDAQ: CV) registers 2.87M PIPE shares for resale - Stock Titan
Tue, 21 Apr 2026
CV|CapsoVision Inc|Price:5.960|Chg%:0.01 - TradingKey
Sat, 18 Apr 2026
CapsoVision (CV) Stock Initiates Position (Froths) 2026-04-18 - Company Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
Fri, 17 Apr 2026
Existing holders of CapsoVision (NASDAQ: CV) register 2.87M PIPE shares for resale - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 50 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 36.9 (%) |
| Held by Institutions | 1.5 (%) |
| Shares Short | 1,240 (K) |
| Shares Short P.Month | 409 (K) |
| EPS | -1.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.28 |
| Profit Margin | -186.8 % |
| Operating Margin | -186.5 % |
| Return on Assets (ttm) | -90.7 % |
| Return on Equity (ttm) | -185 % |
| Qtrly Rev. Growth | 13.5 % |
| Gross Profit (p.s.) | 0.14 |
| Sales Per Share | 0.27 |
| EBITDA (p.s.) | -0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -23 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | -5.9 |
| PEG Ratio | 0 |
| Price to Book value | 21.67 |
| Price to Sales | 22.32 |
| Price to Cash Flow | -13.24 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|